Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 42944-42945 [2023-14137]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
42944
Federal Register / Vol. 88, No. 127 / Wednesday, July 5, 2023 / Notices
selected based on expertise in the fields
of pertinent disciplines involved in
injury and violence prevention,
including, but not limited to,
epidemiology, statistics, trauma surgery,
rehabilitation medicine, behavioral
science, health economics, program
evaluation, political science, law,
criminology, and other aspects of injury
management. Federal employees will
not be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
BSC, NCIPC objectives (https://
www.cdc.gov/injury/bsc/).
Department of Health and Human
Services (HHS) policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Board
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. CDC reviews potential candidates
for BSC, NCIPC membership each year
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in September 2024,
or as soon as the HHS selection process
is completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Candidates should
submit the following items:
D Cover letter stating area of expertise
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (i.e., CDC,
National Institutes of Health, Food and
Drug Administration, Substance Abuse
VerDate Sep<11>2014
17:11 Jul 03, 2023
Jkt 259001
and Mental Health Services
Administration, etc.).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–14139 Filed 7–3–23; 8:45 am]
BILLING CODE 4163–18–P
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–14138 Filed 7–3–23; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention
AGENCY:
Notice of Closed Meeting
In accordance with 5 U.S.C. 1009(d),
the Centers for Disease Control and
Prevention (CDC) announces the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Dates: October 3–4, 2023.
Times: 11 a.m.–5 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26506. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
The CDC announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
is a hybrid meeting, accessible both in
person and virtually. It is open to the
public, limited only by the space
available and the number of audio
conference lines and internet conference
accesses. Time will be available for
public comment. The public is also
welcomed to submit written comments
in advance of the meeting, to the contact
person listed in the addresses section
below. Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The combined
number of audio conference lines and
internet conference accesses is 200.
DATES: The meeting will be held on
August 16, 2023, from 8:15 a.m. to 6:00
p.m., EDT. A public comment session
will be held at 5:00 p.m., EDT, and will
conclude at 6:00 p.m., EDT, or following
the final call for public comment,
whichever comes first. Written
comments must be received on or before
August 9, 2023.
ADDRESSES: DoubleTree by Hilton
Augusta, 2651 Perimeter Parkway,
Augusta, GA 30909; Telephone: (706)
855–8100. The conference room will
SUMMARY:
E:\FR\FM\05JYN1.SGM
05JYN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 127 / Wednesday, July 5, 2023 / Notices
have seating for approximately 125
people.
Meeting Information: The USA tollfree dial-in numbers are: +1 669 254
5252 US (San Jose); and +1 646 828
7666 US (New York). The meeting ID is:
160 6763 3819; the Passcode is:
98685439; and the Web conference by
Zoom meeting connection is: https://
cdc.zoomgov.com/j/16067633819?pwd=
RUdiYXlZZHFKanpJOHZ
rcGJIbTlaZz09.
You may submit comments by mail
to: Rashaun Roberts, National Institute
for Occupational Safety and Health
(NIOSH), CDC, 1090 Tusculum Avenue,
Mailstop C–24, Cincinnati, Ohio 45226.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Official, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226; Telephone:
(513) 533–6800; Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
HHS as a final rule; advice on methods
of dose reconstruction, which have also
been promulgated by HHS as a final
rule; advice on the scientific validity
and quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC). In December
2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, was renewed
at appropriate intervals, was rechartered
under Executive Order 13889 on March
22, 2022, and will terminate on March
22, 2024.
Purpose: This Advisory Board is
charged with a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
VerDate Sep<11>2014
17:11 Jul 03, 2023
Jkt 259001
reconstruction efforts performed for this
program; and c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor Program Update;
Department of Energy Program Update;
SEC Petitions Update; Interactive
RadioEpidemiological Program (IREP)
Update; Procedures Review
Finalization/Document Approvals;
Savannah River Site Workgroup Update;
Metals & Control (M&C) Workgroup
Updates, and a Board Work Session.
Agenda items are subject to change as
priorities dictate.
For additional information, please
contact Toll Free 1–800–232–4636.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Authority: 5 U.S.C. 1001 et. seq.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–14137 Filed 7–3–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
42945
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel
Targeting Inflammasomes in Substance
Abuse and HIV.
Date: July 28, 2023.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jenny Raye Browning,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue,
Bethesda, MD 20892, (301) 443–4577,
jenny.browning@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: June 28, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–14144 Filed 7–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Discovery and Molecular Pharmacology.
Date: July 12, 2023.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 88, Number 127 (Wednesday, July 5, 2023)]
[Notices]
[Pages 42944-42945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-14137]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH), National
Institute for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: The CDC announces the following meeting of the Advisory Board
on Radiation and Worker Health (ABRWH or the Advisory Board). This is a
hybrid meeting, accessible both in person and virtually. It is open to
the public, limited only by the space available and the number of audio
conference lines and internet conference accesses. Time will be
available for public comment. The public is also welcomed to submit
written comments in advance of the meeting, to the contact person
listed in the addresses section below. Written comments received in
advance of the meeting will be included in the official record of the
meeting. The public is also welcomed to listen to the meeting by
joining the audio conference (information below). The combined number
of audio conference lines and internet conference accesses is 200.
DATES: The meeting will be held on August 16, 2023, from 8:15 a.m. to
6:00 p.m., EDT. A public comment session will be held at 5:00 p.m.,
EDT, and will conclude at 6:00 p.m., EDT, or following the final call
for public comment, whichever comes first. Written comments must be
received on or before August 9, 2023.
ADDRESSES: DoubleTree by Hilton Augusta, 2651 Perimeter Parkway,
Augusta, GA 30909; Telephone: (706) 855-8100. The conference room will
[[Page 42945]]
have seating for approximately 125 people.
Meeting Information: The USA toll-free dial-in numbers are: +1 669
254 5252 US (San Jose); and +1 646 828 7666 US (New York). The meeting
ID is: 160 6763 3819; the Passcode is: 98685439; and the Web conference
by Zoom meeting connection is: https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09.
You may submit comments by mail to: Rashaun Roberts, National
Institute for Occupational Safety and Health (NIOSH), CDC, 1090
Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226. Written
comments received in advance of the meeting will be included in the
official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Official, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226; Telephone: (513) 533-6800; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines, which have
been promulgated by the HHS as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose estimation
and reconstruction efforts being performed for purposes of the
compensation program; and advice on petitions to add classes of workers
to the Special Exposure Cohort (SEC). In December 2000, the President
delegated responsibility for funding, staffing, and operating the
Advisory Board to HHS, which subsequently delegated this authority to
the CDC. NIOSH implements this responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, was
renewed at appropriate intervals, was rechartered under Executive Order
13889 on March 22, 2022, and will terminate on March 22, 2024.
Purpose: This Advisory Board is charged with a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Considered: The agenda will include discussions on
the following: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC Petitions Update;
Interactive RadioEpidemiological Program (IREP) Update; Procedures
Review Finalization/Document Approvals; Savannah River Site Workgroup
Update; Metals & Control (M&C) Workgroup Updates, and a Board Work
Session. Agenda items are subject to change as priorities dictate.
For additional information, please contact Toll Free 1-800-232-
4636.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Authority: 5 U.S.C. 1001 et. seq.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-14137 Filed 7-3-23; 8:45 am]
BILLING CODE 4163-18-P
